Reference
Jeong SM, et al. From metastatic melanoma to complete response in seven months: The power of combined checkpoint immunotherapy. Journal of Investigative Medicine 66: 442, No. 2, Feb 2018 [abstract] - USA
Rights and permissions
About this article
Cite this article
Ipilimumab/nivolumab. Reactions Weekly 1696, 216 (2018). https://doi.org/10.1007/s40278-018-44404-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44404-9